We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+17.99%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
-$12.1M
Cap. Flow
-$142M
Cap. Flow %
-13.41%
Top 10 Hldgs %
37.54%
Holding
501
New
15
Increased
262
Reduced
172
Closed
24

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$6.54M
2
IAUM icon
iShares Gold Trust Micro
IAUM
+$4.59M
3
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$3.58M
4
INTU icon
Intuit
INTU
+$3.2M
5
TMUS icon
T-Mobile US
TMUS
+$2.41M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.2M
2
MSFT icon
Microsoft
MSFT
+$10M
3
NVDA icon
NVIDIA
NVDA
+$9.7M
4
AMZN icon
Amazon
AMZN
+$7.99M
5
AVGO icon
Broadcom
AVGO
+$6.64M

Sector Composition

Rank Sector Weight
1 Technology 38.15%
2 Healthcare 22.68%
3 Communication Services 12.64%
4 Consumer Discretionary 11.62%
5 Consumer Staples 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSTL icon
351
Castle Biosciences
CSTL
$960M
$118K 0.01%
5,799
+80
+1% +$1.48K
PSNL icon
352
Personalis
PSNL
$1.52B
$116K 0.01%
17,740
+36
+0.2% +$167
IOVA icon
353
Iovance Biotherapeutics
IOVA
$3.05B
$115K 0.01%
67,069
+1,303
+2% +$3.24K
AMLX icon
354
Amylyx Pharmaceuticals
AMLX
$2.6B
$115K 0.01%
17,904
+716
+4% +$3.48K
SAGE
355
DELISTED
Sage Therapeutics
SAGE
$115K 0.01%
12,577
+245
+2% +$1.8K
KALV
356
DELISTED
KalVista Pharmaceuticals
KALV
$113K 0.01%
9,985
+73
+0.7% +$892
XNCR icon
357
Xencor
XNCR
$1.72B
$112K 0.01%
14,294
+161
+1% +$1.45K
TRVI icon
358
Trevi Therapeutics
TRVI
$2.53B
$112K 0.01%
20,435
+2,510
+14% +$15.6K
TNGX icon
359
Tango Therapeutics
TNGX
$4.31B
$111K 0.01%
21,771
+86
+0.4% +$213
TBPH icon
360
Theravance Biopharma
TBPH
$878M
$111K 0.01%
10,043
+179
+2% +$1.74K
KROS icon
361
Keros Therapeutics
KROS
$222M
$109K 0.01%
8,157
+21
+0.3% +$284
ARVN icon
362
Arvinas
ARVN
$580M
$108K 0.01%
14,660
+866
+6% +$6.38K
MGTX icon
363
MeiraGTx Holdings
MGTX
$1.2B
$105K 0.01%
16,141
+465
+3% +$2.75K
PAHC icon
364
Phibro Animal Health
PAHC
$1.37B
$104K 0.01%
4,091
+12
+0.3% +$262
SIVR icon
365
abrdn Physical Silver Shares ETF
SIVR
$4.53B
$103K 0.01%
3,000
– –
TYRA icon
366
Tyra Biosciences
TYRA
$1.51B
$102K 0.01%
10,681
+531
+5% +$5.04K
KURA icon
367
Kura Oncology
KURA
$882M
$100K 0.01%
17,388
+1,190
+7% +$7.29K
MESO
368
Mesoblast
MESO
$2.18B
$99.4K 0.01%
9,124
+2,302
+34% +$25.8K
DFTX
369
Definium Therapeutics
DFTX
$5.68B
$98.5K 0.01%
15,175
+466
+3% +$3.06K
ZVRA icon
370
Zevra Therapeutics
ZVRA
$679M
$96.8K 0.01%
10,982
+276
+3% +$2.24K
HCM icon
371
HUTCHMED
HCM
$2.13B
$93.8K 0.01%
6,230
+9
+0.1% +$132
SIGA icon
372
SIGA Technologies
SIGA
$206M
$93.6K 0.01%
14,349
+26
+0.2% +$156
AUTL
373
Autolus Therapeutics
AUTL
$564M
$91.8K 0.01%
40,273
+73
+0.2% +$121
FTRE icon
374
Fortrea Holdings
FTRE
$1.74B
$89.8K 0.01%
18,177
+185
+1% +$995
CGEM icon
375
Cullinan Oncology
CGEM
$1.26B
$89.3K 0.01%
11,853
+116
+1% +$932
13 14
15
16 17

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q2 2025 Portfolio in Review

As of Q2 2025, China Universal Asset Management Company held 501 positions worth $1.06B, down 1.1% from $1.07B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

China Universal Asset Management Company withdrew a net $142M in Q2 2025, closing 24 positions and reducing 172 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $2.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, China Universal Asset Management Company opened a new position in Tencent Music worth $1.66M.

  • China Universal Asset Management Company's largest Q2 2025 buy was Tencent Music: 85,000 shares worth $1.66M.
  • China Universal Asset Management Company added most to SPDR Gold Trust in Q2 2025, an estimated $6.54M increase.
  • China Universal Asset Management Company's biggest Q2 2025 reduction was Apple, cutting an estimated $17.2M.
  • China Universal Asset Management Company fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $2.81M.
  • China Universal Asset Management Company's ten largest holdings make up 38% of its $1.06B portfolio in Q2 2025.
  • China Universal Asset Management Company opened 15 new positions and closed 24 in Q2 2025.
  • China Universal Asset Management Company's portfolio value fell 1.1% quarter-over-quarter to $1.06B.

Based on China Universal Asset Management Company's 13F filing for Q2 2025, filed 28 Aug 2025.